Share this article
LIMA, Peru, March 8, 2021 /PRNewswire/ InRetail Pharma, S.A. a corporation (
sociedad anónima) incorporated under the laws of the Republic of Peru ( InRetail Pharma , the Company or we ), today announced that it has commenced a cash tender offer, on the terms and subject to the conditions set forth in the Company s Offer to Purchase and Consent Solicitation Statement dated March 8, 2021 (the Statement ), for any and all of its outstanding 5.375% Senior Notes due 2023 (the Notes ).
The Company is also soliciting consents to certain proposed amendments to the senior notes indenture governing the Notes to, among other things, eliminate substantially all of the restrictive covenants and certain events of default and reduce the minimum notice period required for optional redemptions of the Notes to three days on the terms and subject to the conditions set forth in the Statement.